Antiemetic effect of ondansetron 0.2 mg mL-1 in PCA morphine solution

European Journal of Anaesthesiology

Volumn 24, Issue 8, 2007, Pages 664-667

  Boonmak, P ^a   Boonmak, S ^a   Bunsaengjaroen, P ^a   Srichaipanha, S ^a   Poomsawat, S ^a   Nonlhaopol, D ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Analgesia; Morphine; Ondansetron; Patient controlled; Postoperative nausea and vomiting

Indexed keywords

ATRACURIUM; ATROPINE; MORPHINE; NEOSTIGMINE; NITROUS OXIDE; ONDANSETRON; ONSIA; SUXAMETHONIUM; THIOPENTAL; UNCLASSIFIED DRUG;

ADD ON THERAPY; ADULT; AGED; ANTIEMETIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; ELECTIVE SURGERY; FEMALE; HUMAN; INCIDENCE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; PATIENT SATISFACTION; POSTOPERATIVE NAUSEA AND VOMITING; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SMOKING; TREATMENT DURATION;

ANALGESIA, PATIENT-CONTROLLED; ANESTHESIA, SPINAL; ANTIEMETICS; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; ONDANSETRON; PAIN MEASUREMENT; PATIENT SATISFACTION; POSTOPERATIVE NAUSEA AND VOMITING;

EID: 34447568193     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021507000208     Document Type: Article

References (14)

1. Walder B, Schafer M, Henzi I, Tramer MR. Efficacy and safety of patient-controlled opioid analgesia for acute postoperative pain. A quantitative systematic review. Acta Anaesthesiol Scand 2001; 45: 795-804.
2. Tramer MR, Walder B. Efficacy and adverse effects of prophylactic antiemetics during patient-controlled analgesia therapy: a quantitative systematic review. Anesth Analg 1999; 88: 1354-1361.
3. Hill RP, Lubarsky DA, Phillips-Bute B et al. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology 2000; 92: 958-967.
4. Apfel CC, Korttila K, Abdalla M et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004; 350: 2441-2451.
5. Tang J, Wang B, White PF, Watcha MF, Qi J, Wender RH. The effect of timing of ondansetron administration on its efficacy, cost-effectiveness, and cost-benefit as a prophylactic antiemetic in the ambulatory setting. Anesth Analg 1998; 86: 274-282.
6. Munro FJ, Fisher S, Dickson U, Morton N. The addition of antiemetics to the morphine solution in patient controlled analgesia syringes used by children after an appendectomy does not reduce the incidence of postoperative nausea and vomiting. Paediatr Anaesth 2002; 12: 600-603.
7. Dresner M, Dean S, Lumb A, Bellamy M. High-dose ondansetron regimen vs droperidol for morphine patient-controlled analgesia. Br J Anaesth 1998; 81: 384-386.
8. Habib AS, Gan TJ. Evidence-based management of postoperative nausea and vomiting: a review. Can J Anaesth 2004; 51: 326-341.
9. Biedler A, Wermelt J, Kunitz O et al. A risk adapted approach reduces the overall institutional incidence of postoperative nausea and vomiting. Can J Anaesth 2004; 51: 13-19.
10. Sanansilp V, Soontarinka S, Kantigal P et al. Adding droperidol to morphine patient-controlled analgesia: effect on nausea and vomiting. J Med Assoc Thai 2002; 85: S923-S933.
11. Alexander R, Lovell AT, Seingry D, Jones RM. Comparison of ondansetron and droperidol in reducing postoperative nausea and vomiting associated with patient-controlled analgesia. Anaesthesia 1995; 50: 1086-1088.
12. White PF, Watcha MF. Postoperative nausea and vomiting: prophylaxis versus treatment. Anesth Analg 1999; 89: 1337-1339.
13. Fisher DM. Surrogate outcomes: meaningful not! Anesthesiology 1999; 90: 355-356.
14. Cherian VT, Smith I. Prophylactic ondansetron does not improve patient satisfaction in women using PCA after Caesarean section. Br J Anaesth 2001; 87: 502-504.